ValACYclovir 500 mg Oral Tablet
RxNorm 313565
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 313565 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: valACYclovir 500 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Valacyclovir 500 mg Oral Tablet
(Atom ID: 1463003)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely valaciclovir (as valaciclovir hydrochloride) 500 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10318185)
SYPrescribable
Synonym (SY):
Valaciclovir (as valaciclovir hydrochloride) 500 mg oral tablet
(Atom ID: 10322200)
SYPrescribable
Synonym (SY):
Valacyclovir (as valacyclovir HCl) 500 mg Oral Tablet
(Atom ID: 8719213)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ValACYclovir (as valACYclovir HCl) 500 mg Oral Tablet
(Atom ID: 8724513)
PTPrescribable
Designated preferred name (PT):
Valacyclovir (as valacyclovir hydrochloride) 500 mg oral tablet
(Atom ID: 10322204)
PSNPrescribable
Prescribable Name (PSN):
ValACYclovir 500 mg Oral Tablet
(Atom ID: 6371398)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
ValACYclovir 500 mg Oral Tablet
(Atom ID: 3736837)
Patient Education
Valacyclovir
Valacyclovir is used to treat herpes zoster (shingles) and genital herpes. It does not cure herpes infections but decreases pain and itching, helps sores to heal, and prevents new ones from forming. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.